Back to Newsroom
Back to Newsroom

Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics

Wednesday, 21 July 2021 07:30 AM

Enzolytics, Inc.

Topic:
Company Update

The following press release is no longer available.

 

 

Topic:
Company Update
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: